CompletedNCT02932605
Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia
This study has finished and is no longer accepting participants.
In UtrechtSchizophreniaMedication studyAges 16–40
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
TerminatedNCT01817387
Enhancing Motivation in Recent Onset Schizophrenia
Official study title
Developing an Intervention Strategy to Enhance Motivation in Recent Onset Schizophrenia
This study ended early.
In San FranciscoSchizophreniaBehavioural studyAges 14–30
CompletedNCT01776112
Enhancing Synaptic Plasticity and Cognition in Schizophrenia
Official study title
Enhancing Synaptic Plasticity and Cognition by Physical Exercise and Cognitive Training in Schizophrenia: A Randomised Controlled Trial
This study has finished and is no longer accepting participants.
In GöttingenSchizophreniaPlacebo comparisonAges 18–55
CompletedNCT00069433
Enhancing the Outcome of Skills Training for People With Schizophrenia
Official study title
Skills Training for Schizophrenia: Enhancing Outcomes
This study has finished and is no longer accepting participants.
Multiple locations, including BridgeportSchizophreniaInterventional studyAges 18–55
CompletedNCT00192855
Entacapone Augmentation for Schizophrenia
Official study title
Entacapone Augmentation for Schizophrenia- A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In HaifaSchizophreniaMedication studyAges 18–75
CompletedNCT00984373
Epidemiology of Schizophrenia in Bulgaria
Official study title
Epidemiological Study to Describe Approaches in Diagnosis, Treatment and Social Functioning of Schizophrenic Patients in Bulgaria
This study has finished and is no longer accepting participants.
Multiple locations, including BurgasSchizophreniaObservational studyAges 18+
CompletedNCT01021449
Epigenetic Regulation of BDNF in Schizophrenia
Official study title
Epigenetic Regulation of BDNF and TrK B in Schizophrenic Patients
This study has finished and is no longer accepting participants.
In Kaohsiung CitySchizophreniaObservational studyAges 18–65
CompletedNCT00456937
Escitalopram in Schizophrenia in OCD- Open Label Study
Official study title
Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study
This study has finished and is no longer accepting participants.
In Beer YaakovSchizophrenia, OCDMedication studyAges 18–65
CompletedNCT05206292
Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in people with Psychotic Disorders.
Official study title
Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.
This study has finished and is no longer accepting participants.
In GrenobleSchizophreniaStudy assessmentsAges 18+
CompletedNCT02146547
European Long-acting Antipsychotics in Schizophrenia study
Official study title
European Long-acting Antipsychotics in Schizophrenia Trial
This study has finished and is no longer accepting participants.
Multiple locations, including InnsbruckSchizophreniaMedication studyAges 18+
CompletedNCT04572685
Evaluate the PK of LY03010 Process 1 and Process 2 Drug Product vs INVEGA SUSTENNA After Intramuscular Injection for schizophrenia
Official study title
A Randomized, Open-Label, Parallel, Single-Dose Study to Evaluate the Pharmacokinetic Characteristics of LY03010 Process 1 and Process 2 Drug Product Versus INVEGA SUSTENNA After Intramuscular Injection in Schizophrenia Patients
This study has finished and is no longer accepting participants.
In BerlinSchizophreniaMedication studyAges 18–65
CompletedNCT01891721
Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesSchizophreniaBehavioural studyAges 25–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.